Hangzhou Zenshine Pharmaceuticals Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Hangzhou China (2018)

Organization Overview

First Clinical Trial
2020
NCT04504708
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hangzhou Zenshine Pharmaceuticals Co., Ltd. | Nanjing Zenshine Pharmaceuticals | Zenshine Pharmaceutical, Inc. | Zenshine Pharmaceuticals